Trials / Unknown
UnknownNCT02082054
StahistRx Phase 2, Five-arm, Parallel Group, Active vs Active, Double-blind Study
A Phase 2, Double-Blind, Parallel-Group, Dose-Ranging Study Evaluating Safety/ Efficacy Atropine Doses With Pseudoephedrine and Chlorpheniramine in SAR Patients 12 Years of Age and Older
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 125 (estimated)
- Sponsor
- Magna Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- 12 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This active vs active comparative trial will evaluate the safety and efficacy of incremental doses of atropine in combination with pseudoephedrine 120 mg/chlorpheniramine 8 mg in adult patients with a history of seasonal allergic rhinitis. Hypotheses are defined by total nasal symptom scores (TNSS) recorded by subjects in diaries where efficacy will be established by statistical significance where p \< 0.05.
Detailed description
Actives in each of the five study arms: Pseudoephedrine 120 mg/Chlorpheniramine 8 mg/Atropine 0.36 mg Pseudoephedrine 120 mg/Chlorpheniramine 8 mg/Atropine 0.24 mg Pseudoephedrine 120 mg/Chlorpheniramine 8 mg/Atropine 0.12 mg Pseudoephedrine 120 mg/Chlorpheniramine 8 mg Atropine 0.24 mg
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PSE 120 mg, CM 8 mg, Atr 0.36 mg | Pseudoephedrine 120 mg, chlorpheniramine 8 mg, atropine 0.36 mg white, scored, tablets with "M27" on scored side and plain on the other side |
| DRUG | PSE 120 mg, CM 8 mg, Atr 0.24 mg | Pseudoephedrine 120 mg, chlorpheniramine 8 mg, atropine 0.24 mg white, scored, tablets with "M27" on scored side and plain on the other side |
| DRUG | PSE 120 mg, CM 8 mg, Atr 0.12 mg | Pseudoephedrine 120 mg, chlorpheniramine 8 mg, atropine 0.12 mg white, scored, tablets with "M27" on scored side and plain on the other side |
| DRUG | PSE 120 mg, CM 8 mg | Pseudoephedrine 120 mg, chlorpheniramine 8 mg tablets dosed BID |
| DRUG | Atropine 0.24 mg | Atropine sulfate 0.24 mg white, scored, tablets with "M27" on scored side and plain on the other side |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2014-05-01
- Completion
- 2014-05-01
- First posted
- 2014-03-10
- Last updated
- 2014-05-30
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02082054. Inclusion in this directory is not an endorsement.